Carregant...

The Role of Immunotherapy in Multiple Myeloma

Multiple myeloma is the second most common hematologic malignancy. The treatment of this disease has changed considerably over the last two decades with the introduction to the clinical practice of novel agents such as proteasome inhibitors and immunomodulatory drugs. Basic research efforts towards...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmaceuticals (Basel)
Autors principals: Kocoglu, Mehmet, Badros, Ashraf
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4812367/
https://ncbi.nlm.nih.gov/pubmed/26784207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph9010003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!